Journal of Cancer Research and Clinical Oncology

, Volume 137, Issue 2, pp 347–357 | Cite as

Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa)

  • Gargi Maity
  • Triparna Sen
  • Amitava Chatterjee
Original Paper



Interaction between cell surface integrin receptors and extracellular matrix (ECM) components plays an important role in cell survival, proliferation and migration including tumor development and invasion. Matrix metalloproteinases (MMP) are a family of metalloproteinases capable of digesting ECM and facilitate cell migration. Binding of ECM to integrins initiates signaling cascades modulating expression and activity of different MMPs. The present study investigates whether laminin-mediated signaling modulates matrix metalloproteinases (MMP) expression and activity in human cervical cancer cell (SiHa).


Western blot, immunocytochemistry, ELISA, zymography, RT–PCR, EMSA and wound-healing assay were used.


Culture of SiHa cells on laminin (LN)-coated surface induces MMP-9 expression and activation. Wound-healing assay showed that SiHa cells migrate much faster on laminin-coated surface than that of control. LN-induced MMP-9 expression and activation was appreciably reduced with treatment of extracellular signal–regulated kinase (ERK) inhibitor, phosphatidylinositol-3-kinase (PI-3K) inhibitor and anti-α2 antibody. Phosphorylation of focal adhesion kinase (FAK), ERK, and PI-3K was increased upon LN stimulation. LN induces nuclear translocation of PI-3K and nuclear factor kappa B (NF-κB). LN increases DNA-binding activity of NF-κB and activator protein-1 (AP-1) to MMP-9 promoter.


Our findings indicate laminin-induced MMP-9 expression and activation possibly via α2β1 integrin-mediated signaling involving FAK, PI-3K, ERK followed by transcriptional upregulation of MMP-9.


Laminin Integrin MMP-9 ERK PI-3K NF-κB 



We acknowledge Director, Chittaranjan National Cancer Institute for Institute facilities, financial support and Department of Science and Technology, New Delhi (Grant No. SR/SO/HS-59/2004) for financial support.

Conflict of interest statement



  1. Aicher WK, Pap T, Gay S (2008) Laminin-dependent inflammatory response in synovial fibroblasts of rheumatoid arthritis patients. Z Rheumatol 67:59–61CrossRefPubMedGoogle Scholar
  2. Avraamides CJ, Garmy-Susini B, Varner JA (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8:604–617CrossRefPubMedGoogle Scholar
  3. Baba Y, Iyama KI, Hirashima K, Nagai Y, Yoshida N, Hayashi N, Miyanari N, Baba H (2008) Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation. Br J Cancer 98:974–980CrossRefPubMedGoogle Scholar
  4. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R (2002) Intergins in invasive growth. J Clin Invest 109:999–1006PubMedGoogle Scholar
  5. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283CrossRefPubMedGoogle Scholar
  6. Das S, Banerji A, Frei E, Chatterjee A (2008) Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 82:467–476CrossRefPubMedGoogle Scholar
  7. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34CrossRefPubMedGoogle Scholar
  8. DiPersio CM, Shao M, Di Costanzo L, Kreidberg JA, Hynes RO (2000) Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. J Cell Sci 113(Pt 16):2909–2921PubMedGoogle Scholar
  9. Ekblom P, Lonai P, Talts JF (2003) Expression and biological role of laminin-1. Matrix BiolGoogle Scholar
  10. Freitas VM, Vilas-Boas VF, Pimenta DC, Loureiro V, Juliano MA, Carvalho MR, Pinheiro JJ, Camargo AC, Moriscot AS, Hoffman MP, Jaeger RG (2007) SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. Am J Pathol 171:124–138CrossRefPubMedGoogle Scholar
  11. Givant-Horwitz V, Davidson B, Reich R (2005) Laminin-induced signaling in tumor cells. Cancer Lett 223:1–10CrossRefPubMedGoogle Scholar
  12. Grenache DG, Zhang Z, Wells LE, Santoro SA, Davidson JM, Zutter MM (2007) Wound healing in the alpha2beta1 integrin-deficient mouse: altered keratinocyte biology and dysregulated matrix metalloproteinase expression. J Invest Dermatol 127:455–466CrossRefPubMedGoogle Scholar
  13. Gu J, Fujibayashi A, Yamada KM, Sekiguchi K (2002a) Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via phosphatidylinositol 3-kinase/Akt- and MEK1/ERK-dependent pathways. J Biol Chem 277:19922–19928CrossRefPubMedGoogle Scholar
  14. Gu J, Nishiuchi R, Sekiguchi K (2002b) Matrix metalloproteinase-2 is involved in A549 cell migration on laminin-10/11. Biochem Biophys Res Commun 296:73–77CrossRefPubMedGoogle Scholar
  15. Han S, Ritzenthaler JD, Sitaraman SV, Roman J (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281:29614–29624CrossRefPubMedGoogle Scholar
  16. Hannigan G, Troussard AA, Dedhar S (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5:51–63CrossRefPubMedGoogle Scholar
  17. Jung SH, Woo MS, Kim SY, Kim WK, Hyun JW, Kim EJ, Kim DH, Kim HS (2006) Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int J Cancer 118:490–497CrossRefPubMedGoogle Scholar
  18. Khan KM, Falcone DJ, Kraemer R (2002) Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 277:2353–2359CrossRefPubMedGoogle Scholar
  19. Kubota S, Tashiro K, Yamada Y (1992) Signaling site of laminin with mitogenic activity. J Biol Chem 267:4285–4288PubMedGoogle Scholar
  20. Kuratomi Y, Nomizu M, Tanaka K, Ponce ML, Komiyama S, Kleinman HK, Yamada Y (2002) Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16–F10 mouse melanoma cells. Br J Cancer 86:1169–1173CrossRefPubMedGoogle Scholar
  21. Lochter A, Navre M, Werb Z, Bissell MJ (1999) Alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 10:271–282PubMedGoogle Scholar
  22. Maity G, Fahreen S, Banerji A, Roy Choudhury P, Sen T, Dutta A, Chatterjee A (2010) Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol Cell Biochem 336:65–74CrossRefPubMedGoogle Scholar
  23. Menard S, Tagliabue E, Colnaghi MI (1998) The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 52:137–145CrossRefPubMedGoogle Scholar
  24. Mitra A, Chakrabarti J, Banerji A et al (2006) Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol 132:505–513CrossRefPubMedGoogle Scholar
  25. Neri LM, Milani D, Bertolaso L, Stroscio M, Bertagnolo V, Capitani S (1994) Nuclear translocation of phosphatidylinositol 3-kinase in rat pheochromocytoma PC 12 cells after treatment with nerve growth factor. Cell Mol Biol (Noisy-le-grand) 40:619–626Google Scholar
  26. Newell KJ, Witty JP, Rodgers WH, Matrisian LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10:199–206CrossRefPubMedGoogle Scholar
  27. Patarroyo M, Tryggvason K, Virtanen I (2002) Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12:197–207CrossRefPubMedGoogle Scholar
  28. Reich R, Blumenthal M, Liscovitch M (1995) Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin Exp Metastasis 13:134–140CrossRefPubMedGoogle Scholar
  29. Sang QX, Birkedal-Hansen H, Van Wart HE (1995) Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta 1251:99–108CrossRefPubMedGoogle Scholar
  30. Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG (2006) Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J Biol Chem 281:8497–8510CrossRefPubMedGoogle Scholar
  31. Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M, Chatterjee A (2009) Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 84:194–204CrossRefPubMedGoogle Scholar
  32. Stack S, Gray RD, Pizzo SV (1991) Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain. Biochemistry 30:2073–2077CrossRefPubMedGoogle Scholar
  33. Takahra T, Smart DE, Oakley F, Mann DA (2004) Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int J Biochem Cell Biol 36:353–363CrossRefPubMedGoogle Scholar
  34. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R (2003) Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308:386–395CrossRefPubMedGoogle Scholar
  35. Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S (2000) The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19:5444–5452CrossRefPubMedGoogle Scholar
  36. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375–536CrossRefPubMedGoogle Scholar
  37. Wang YG, Ji X, Pabbidi M, Samarel AM, Lipsius SL (2009) Laminin acts via focal adhesion kinase/phosphatidylinositol-3′ kinase/protein kinase B to down-regulate beta1-adrenergic receptor signalling in cat atrial myocytes. J Physiol 587:541–550CrossRefPubMedGoogle Scholar
  38. Waterman EA, Sakai N, Nguyen NT, Horst BA, Veitch DP, Dey CN, Ortiz-Urda S, Khavari PA, Marinkovich MP (2007) A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res 67:4264–4270CrossRefPubMedGoogle Scholar
  39. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13:781–792PubMedGoogle Scholar
  40. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D (2001) Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20:8066–8074CrossRefPubMedGoogle Scholar
  41. Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, Rozenberg GI, Marinkovich MP, Weaver VM (2003) Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163:1397–1407CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of Receptor Biology and Tumor MetastasisChittaranjan National Cancer InstituteKolkataIndia

Personalised recommendations